Importance of intensive blood pressure control in type 2 diabetes: Mechanisms, treatments and current guidelines
Related Experiment Video
Updated: Dec 24, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Michel Marre1,2,3
1INSERM U1138, Centre de Recherches des Cordeliers, Paris, France.
Insights
Intensified blood pressure reduction benefits people with diabetes. Renin-angiotensin-aldosterone system (RAAS) blockers are recommended, supporting updated guidelines for blood pressure targets in diabetic patients.
Area of Science:
- Cardiology
- Diabetology
- Pharmacology
Background:
- Intensified blood pressure (BP) reduction offers benefits for individuals with diabetes.
- Renin-angiotensin-aldosterone system (RAAS) blockers are favored due to their unique hemodynamic properties.
Purpose of the Study:
- To evaluate the impact of intensified BP reduction in people with diabetes.
- To assess the alignment of findings with current European treatment guidelines.
Main Methods:
- Analysis of observational and interventional studies.
- Focus on the blood pressure arm of the ADVANCE study.
Main Results:
- Strong support for intensified BP reduction in diabetic populations.
- Evidence aligns with updated European Society of Cardiology/European Association of Diabetes recommendations.
Conclusions:
- Recommended BP target for people with diabetes is 130/80 mmHg.
- Fixed-dose combinations of RAAS blockers with diuretics or calcium channel blockers are suggested as first-line therapy.
Abstract:
Observational and interventional studies have shown that intensified blood pressure (BP) reduction can benefit people with diabetes. Because of their special haemodynamic properties, renin-angiotensin-aldosterone system (RAAS) blockers are recommended. The results of the BP arm of the ADVANCE study strongly support the recently updated European Society of Cardiology/European Association of Diabetes recommendations for the treatment of BP in people with diabetes, which recommend a target systolic/diastolic BP of 130/80 mmHg with few exceptions, and a fixed combination of an RAAS blocker with a diuretic or a calcium channel blocker as first-line treatment.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Diabetes: Symptoms, Diagnosis, and Complications

